SEARCH RESULT

Total Matching Records found : 3122

A welcome rollback

-The Business Standard Cotton export ban was an example of poor policy The government’s sudden move to ban cotton exports – rolled back in less than a week following anger from cotton farmers and adverse political fallout — reflects very poorly on its policy management. The commerce ministry clamped down on exports without clear logic; prior consultations with other ministries concerned were also cursory or non-existent. Unsurprisingly, most players in the cotton...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times   The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Govt uses special powers to slash cancer drug price by 97%-Rupali Mukherjee

In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...

More »

The time is not ripe

-The Hindustan Times The UPA’s record of policy flip-flops endures. The latest instance is a ban on exports of cotton that seems headed for revocation less than a week after it was announced. The commerce ministry’s line that India has exported more cotton this season than it can afford to without hurting consumption at home does not wash with partners of the ruling alliance or with the political bosses of cotton...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close